Research

Adherence

Current clinical guidelines recommend individualized perioperative management for GLP-1 RA users, with recent consensus shifting from mandatory discontinuation to risk-based assessment based on gastrointestinal symptoms and treatment duration.

Do not stop your GLP-1 medication on your own before surgery. Recent guidelines say you should likely keep taking it unless you have severe nausea or vomiting. Your surgical team will create a specific plan for you, possibly adjusting your fasting rules, to keep your blood sugar stable while minimizing lung risks.

GoodSupportsHIGH confidence
Current preoperative assessment for patients treated with GLP-1 RAs emphasizes individualized evaluation based on the route of administration, duration of therapy, and presence of gastrointestinal symptoms, suggesting that tailored management according to patient-specific risk is more appropriate than a uniform prolongation of fasting periods.
Donghee Kang et al. · The Korean Journal of Internal Medicine · 2026

Why this rating

Based on consensus statements from major anesthesia societies (ASA, BJA).

Source

Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia

Donghee Kang et al. · The Korean Journal of Internal Medicine · 2026

narrative_review
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →